Research using mouse models of AML have demonstrated that tumor progression correlates with an increase in regulatory T cells (Tregs) among infiltrating CD8+ T cells in the liver, resulting in upregulation of PD-1 expression and subsequent impairment of CD8+ T cell functionality (6, 7). This evidence concerns the gene CD8A and neoplasm.